Results 251 to 257 of about 23,280 (257)

Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate 西格列汀通过降低2型糖尿病患者的血压以及估算的肾小球滤过率来减少尿白蛋白/肌酐的比值

Journal of Diabetes, 2015
Masayuki Hosoi
exaly  

Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

Drugs, 2014
Greg L Plosker
exaly  

Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan

European Journal of Internal Medicine, 2016
Cheng-Li Lin, Shih-Wei Lai
exaly  

Sitagliptin

Reactions Weekly, 2011
openaire   +2 more sources

Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes

Tohoku Journal of Experimental Medicine, 2011
Susumu Ogawa, Sadayoshi Itō, Miho Senda
exaly  

Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats

Experimental Biology and Medicine, 2016
Mohamed A Elkablawy, Dina S El-Agamy, Hany M Abo-Haded   +2 more
exaly  

Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

Clinical Therapeutics, 2007
exaly